Yongin-si, South Korea

Ha Been Park


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Ha Been PARK in the Field of Contrast Agents**

Introduction

Ha Been PARK, an inventive mind based in Yongin-si, South Korea, has made significant strides in the realm of medical technology. With one registered patent to his name, PARK showcases creativity and innovation that can benefit the medical field, particularly in imaging procedures.

Latest Patents

PARK's noteworthy patent involves a “Vegetable oil-derived contrast agent with high stability and preparation method thereof.” This invention proposes a contrast agent that integrates an iodinated unsaturated fatty acid ethyl ester derived from vegetable oil, a non-iodinated unsaturated fatty acid ethyl ester, and sulfur dioxide (SO). By utilizing vegetable oil as a more stable and cost-effective substitute for traditional poppy seed oil, which often poses supply challenges, PARK addresses both economic and stability concerns. Additionally, the formulation significantly enhances the long-term stability of iodine-based contrast agents by incorporating sulfur dioxide along with a non-iodinated fatty acid ethyl ester, thereby paving the way for safer imaging processes.

Career Highlights

PARK is associated with Engain Co., Ltd., where he continues to push the boundaries of innovation. His work emphasizes blending traditional methods with novel approaches to enhance medical imaging tools. His dedication to refining contrast agents illustrates his importance to the field and his commitment to improving patient outcomes.

Collaborations

Throughout his career, PARK has collaborated with notable colleagues like Won Mok Lee and Kyoung Ho Kim. Together, they have fostered a culture of innovation at Engain Co., Ltd., contributing to advancements that leverage both teamwork and interdisciplinary ideas to enhance medical practices.

Conclusion

Ha Been PARK stands as a testament to the power of innovation within the medical sector, particularly in the development of contrast agents. His patent reflects a promising direction towards making imaging procedures more effective and economically viable. As he continues to work with Engain Co., Ltd., there is no doubt that PARK will contribute even further to the advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…